1. In Memoriam: Donald L. Morton, MD (1934–2014): An Icon in Surgical Oncology

   • Charles M. Balch
   • Mark S. Roh
   • Deborah A. Whippen

   Healthcare Policy and Outcomes 17 March 2014 Pages: 1413 - 1416

   

2. The End of the Beginning: Society of Surgical Oncology 2013 Presidential Address

   • Monica Morrow

   Healthcare Policy and Outcomes 07 March 2014 Pages: 1417 - 1425

   

3. Regional Therapies for Advanced Cancer

   • K. K. Turaga
   • T. C. Gamblin

   Regional Cancer Therapies 25 February 2014 Pages: 1426 - 1428

4. Ovarian Cancer: A Brief Historical Overview of Intraperitoneal Trials

   • Maryann Kwa
   • Franco Muggia

   Original Article – Regional Cancer Therapies 01 October 2013 Pages: 1429 - 1434

5. Hypoxia in Melanoma: Using Optical Spectroscopy and EF5 to Assess Tumor Oxygenation Before and During Regional Chemotherapy for Melanoma

   • Paul J. Speicher
   • Georgia M. Beasley
   • Douglas S. Tyler

   Regional Cancer Therapies 28 August 2013 Pages: 1435 - 1440

   

6. Pseudomyxoma Peritonei: Inflammatory Responses in the Peritoneal Microenvironment

   • Kush Lohani
   • Shreya Shetty
   • Brian Loggie

   Regional Cancer Therapies 18 September 2013 Pages: 1441 - 1447

   

7. Aggressive Locoregional Surgical Therapy for Gastric Peritoneal Carcinomatosis

   • Deepa Magge
   • Mazen Zenati
   • Haroon A. Choudry

   Regional Cancer Therapies 07 November 2013 Pages: 1448 - 1455

   

8. Impact of Aggressive Histology and Location of Primary Tumor on the Efficacy of Surgical Therapy for Peritoneal Carcinomatosis of Colorectal Origin

   • Joshua Winer
   • Mazen Zenati
   • Haroon A. Choudry

   Regional Cancer Therapies 08 November 2013 Pages: 1456 - 1462

   

9. The Effect of Elevated Body Mass Index on Outcomes Following Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy

   • Sarah J. McPartland
   • Martin D. Goodman

   Regional Cancer Therapies 01 October 2013 Pages: 1463 - 1467

   

10. Ovarian Cancer in BRCA Mutation Carriers: Improved Outcome After Intraperitoneal (IP) Cisplatin

    • Maryann Kwa
    • Susan Edwards
    • Franco Muggia

    Regional Cancer Therapies 01 October 2013 Pages: 1468 - 1473

11. Efficacy of Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy in the Management of Malignant Ascites

    • Reese W. Randle
    • Katrina R. Swett
    • Konstantinos I. Votanopoulos

    Regional Cancer Therapies 28 August 2013 Pages: 1474 - 1479

    

12. Repeat Cytoreductive Surgery and Heated Intraperitoneal Chemotherapy May Offer Survival Benefit for Intraperitoneal Mesothelioma: A Single Institution Experience

    • Joyce Wong
    • Abigail L. Koch
    • Sophie Dessureault

    Regional Cancer Therapies 25 October 2013 Pages: 1480 - 1486

    

13. Safety of Epidural Analgesia in the Perioperative Care of Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy

    • Pascal Owusu-Agyemang
    • Jose Soliz
    • Vijaya Gottumukkala

    Original Article -– Regional Cancer Therapies 28 August 2013 Pages: 1487 - 1493

    

14. Morbidity and Mortality of Cytoreduction with Intraperitoneal Chemotherapy: Outcomes from the ACS NSQIP Database

    • Edmund K. Bartlett
    • Chelsey Meise
    • Giorgos C. Karakousis

    Regional Cancer Therapies 29 August 2013 Pages: 1494 - 1500

    

15. Consensus Guidelines from The American Society of Peritoneal Surface Malignancies on Standardizing the Delivery of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Colorectal Cancer Patients in the United States

    • K. Turaga
    • E. Levine
    • J. Esquivel

    Gastrointestinal Oncology 21 June 2013 Pages: 1501 - 1505

16. Big Data and Clinical Research in Oncology: The Good, the Bad, the Challenges, and the Opportunities

    • Christopher M. Pezzi

    Healthcare Policy and Outcomes 20 February 2014 Pages: 1506 - 1507

17. Neoadjuvant Chemotherapy for Localized Pancreatic Cancer: Too Little or Too Long?

    • Rebekah R. White
    • Douglas B. Evans

    Pancreatic Tumors 23 January 2014 Pages: 1508 - 1509

18. Magnetic Resonance Imaging in Patients with Ductal Carcinoma in Situ: Routine, Selective, or not at all?

    • Julie A. Margenthaler

    Breast Oncology 25 December 2013 Pages: 1510 - 1511

19. Cost Implications of the SSO-ASTRO Consensus Guideline on Margins for Breast-Conserving Surgery with Whole Breast Irradiation in Stage I and II Invasive Breast Cancer

    • Rachel A. Greenup
    • Jeffrey Peppercorn
    • E. Shelley Hwang

    Breast Oncology 28 February 2014 Pages: 1512 - 1514

20. Invited Commentary on “Thoraco-pleuro-pneumonectomy (TPP) with Riblike Reconstruction for Recurrent Thoracic Sarcomas” by A. Gronchi et al., (ASO-2013-09-1533.R1)

    • Thomas L. Bauer
    • David B. Berkheim

    Bone and Soft Tissue Sarcomas 23 January 2014 Pages: 1515 - 1516

21. The Role of Sentinel Lymph Node Biopsy in Patients with Merkel Cell Carcinoma: Uncertainty Prevails

    • John F. Thompson
    • George Hruby

    Melanomas 07 March 2014 Pages: 1517 - 1519

22. Cancer Recurrence: An Important but Missing Variable in National Cancer Registries

    • Haejin In
    • Karl Y. Bilimoria
    • David P. Winchester

    Healthcare Policy and Outcomes 07 February 2014 Pages: 1520 - 1529

    

23. Extended Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer Demonstrates Promising Postoperative Outcomes and Survival

    • J. Bart Rose
    • Flavio G. Rocha
    • Scott Helton

    Hepatobiliary Tumors 29 January 2014 Pages: 1530 - 1537

    

24. Erratum to: Extended Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer Demonstrates Promising Postoperative Outcomes and Survival

    • J. Bart Rose
    • Flavio G. Rocha
    • Scott Helton

    Erratum 17 March 2014 Pages: 1538 - 1538

25. Comparison of Preoperative Conference-Based Diagnosis with Histology of Cystic Tumors of the Pancreas

    • Marco Del Chiaro
    • Ralf Segersvärd
    • Caroline Verbeke

    Pancreatic Tumors 03 January 2014 Pages: 1539 - 1544

    

26. Revisiting the Concept of Lymph Node Metastases of Pancreatic Head Cancer: Number of Metastatic Lymph Nodes and Lymph Node Ratio According to N Stage

    • Mee Joo Kang
    • Jin-Young Jang
    • Sun-Whe Kim

    Pancreatic Tumors 14 January 2014 Pages: 1545 - 1551

    

27. Perioperative Breast MRI Is Not Associated with Lower Locoregional Recurrence Rates in DCIS Patients Treated With or Without Radiation

    • Melissa Pilewskie
    • Cristina Olcese
    • Kimberly J. Van Zee

    Breast Oncology 03 January 2014 Pages: 1552 - 1560

    

28. Low Prognostic Implication of Fibroblast Growth Factor Family Activation in Triple-negative Breast Cancer Subsets

    • Hee Jin Lee
    • An Na Seo
    • Gyungyub Gong

    Breast Oncology 03 January 2014 Pages: 1561 - 1568

    

29. Impact of Molecular Subtype on Locoregional Recurrence in Mastectomy Patients with T1–T2 Breast Cancer and 1–3 Positive Lymph Nodes

    • Tracy-Ann Moo
    • Robert McMillan
    • Mahmoud El-Tamer

    Breast Oncology 01 February 2014 Pages: 1569 - 1574

    

30. Long-Term Outcome of Neoadjuvant Endocrine Therapy with Aromatase Inhibitors in Elderly Women with Hormone Receptor-Positive Breast Cancer

    • Antonino Grassadonia
    • Marta Di Nicola
    • Ettore Cianchetti

    Breast Oncology Open access 13 February 2014 Pages: 1575 - 1582

    

31. MRI Volumetric Analysis of Breast Fibroglandular Tissue to Assess Risk of the Spared Nipple in BRCA1 and BRCA2 Mutation Carriers

    • Heather L. Baltzer
    • Olivier Alonzo-Proulx
    • John L. Semple

    Breast Oncology 14 February 2014 Pages: 1583 - 1588

    

32. A Randomized Prospective Study of Lumpectomy Margin Assessment with Use of MarginProbe in Patients with Nonpalpable Breast Malignancies

    • Freya Schnabel
    • Susan K. Boolbol
    • Tanir Allweis

    Breast Oncology Open access 05 March 2014 Pages: 1589 - 1595

    

33. Thoracic Lymph Node Involvement in Adenocarcinoma of the Esophagogastric Junction and Lower Esophageal Squamous Cell Carcinoma Relative to the Location of the Proximal End of the Tumor

    • Shinji Mine
    • Takeshi Sano
    • Toshiharu Yamaguchi

    Breast Oncology 15 February 2014 Pages: 1596 - 1601

    

34. Photoacoustic and Fluorescence Image-Guided Surgery Using a Multifunctional Targeted Nanoprobe

    • Lei Xi
    • Guangyin Zhou
    • Huabei Jiang

    Breast Oncology 20 February 2014 Pages: 1602 - 1609

    

35. Thoracopleuropneumonectomy with Riblike Reconstruction for Recurrent Thoracic Sarcomas

    • Ugo Pastorino
    • Leonardo Duranti
    • Alessandro Gronchi

    Bone and Soft Tissue Sarcomas 24 January 2014 Pages: 1610 - 1615

    

36. Phase I Trial of Neoadjuvant Conformal Radiotherapy Plus Sorafenib for Patients with Locally Advanced Soft Tissue Sarcoma of the Extremity

    • Robert J. Canter
    • Dariusz Borys
    • Arta M. Monjazeb

    Bone and Soft Tissue Sarcomas 20 February 2014 Pages: 1616 - 1623

    

37. Sentinel Lymph Node Biopsy is Associated with Improved Survival in Merkel Cell Carcinoma

    • Swapnil D. Kachare
    • Jan H. Wong
    • Timothy L. Fitzgerald

    Melanomas 31 December 2013 Pages: 1624 - 1630

    

38. Pushing the Limits of Local Excision for Rectal Cancer: Transanal Minimally Invasive Surgery for an Upper Rectal/Rectosigmoid Lesion

    • Qaali Hussein
    • Avo Artinyan

    Colorectal Cancer 10 January 2014 Pages: 1631 - 1631

39. Bevacizumab Efficacy in Metastatic Colorectal Cancer is Dependent on Primary Tumor Resection

    • Francois Ghiringhelli
    • Damien Bichard
    • Sylvain Ladoire

    Colorectal Cancer Open access 14 January 2014 Pages: 1632 - 1640

    

40. Recurrence Pattern Depends on the Location of Colon Cancer in the Patients with Synchronous Colorectal Liver Metastasis

    • Huisong Lee
    • Dong Wook Choi
    • Ho-Kyung Chun

    Colorectal Cancer 05 February 2014 Pages: 1641 - 1646

    

41. Outcomes of Total Thyroidectomy with Therapeutic Central and Lateral Neck Dissection with a Single Dose of Radioiodine in the Treatment of Regionally Advanced Papillary Thyroid Cancer and Effects on Serum Thyroglobulin

    • David T. Hughes
    • Barbra S. Miller
    • Paul G. Gauger

    Endocrine Tumors 03 January 2014 Pages: 1647 - 1652

    

42. Fine-Needle Aspiration of the Thyroid: Correlating Suspicious Cytology Results with Histological Outcomes

    • Andrea L. Baynes
    • Andres Del Rio
    • Jonathan W. Serpell

    Endocrine Tumors 04 January 2014 Pages: 1653 - 1658

43. Does Extracapsular Extension Impact the Prognosis of Papillary Thyroid Microcarcinoma?

    • Nathalie Chéreau
    • Camille Buffet
    • Fabrice Menegaux

    Endocrine Tumors 07 January 2014 Pages: 1659 - 1664

    

44. Anaplastic Thyroid Carcinoma: A 25-year Single-Institution Experience

    • A. Mohebati
    • M. DiLorenzo
    • I. Ganly

    Endocrine Tumors 20 February 2014 Pages: 1665 - 1670

    

45. Technical Improvement of Total Pharyngo-Laryngo-Esophagectomy for Esophageal Cancer and Head and Neck Cancer

    • Masaru Morita
    • Hiroshi Saeki
    • Yoshihiko Maehara

    Gastrointestinal Oncology 06 January 2014 Pages: 1671 - 1677

    

46. Stage-Stratified Prognosis of Signet Ring Cell Histology in Patients Undergoing Curative Resection for Gastric Adenocarcinoma

    • Zubin M. Bamboat
    • Laura H. Tang
    • Vivian E. Strong

    Gastrointestinal Oncology 07 January 2014 Pages: 1678 - 1685

    

47. Peritoneal Carcinomatosis in T4 Colorectal Cancer: Occurrence and Risk Factors

    • H. C. van Santvoort
    • H. J. Braam
    • B. van Ramshorst

    Gastrointestinal Oncology 08 January 2014 Pages: 1686 - 1691

    

48. Completion Surgery After Concomitant Chemoradiation in Locally Advanced Cervical Cancer: A Comprehensive Analysis of Pattern of Postoperative Complications

    • Gabriella Ferrandina
    • Alfredo Ercoli
    • Giovanni Scambia

    Gynecologic Oncology 10 January 2014 Pages: 1692 - 1699

49. Statistical Analysis of Surgical Site Infection After Head and Neck Reconstructive Surgery

    • Kenichi Kamizono
    • Minoru Sakuraba
    • Ryuichi Hayashi

    Head and Neck Oncology 15 February 2014 Pages: 1700 - 1705

50. Lymph Node Metastasis in T4 Maxillary Sinus Squamous Cell Carcinoma: Incidence and Treatment Outcome

    • Akihiro Homma
    • Ryuichi Hayashi
    • Masato Fujii

    Head and Neck Oncology 20 February 2014 Pages: 1706 - 1710